Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer

Lilly

Status and phase: Completed; Phase 2

Conditions: Carcinoma, Non Small Cell Lung

Treatments: Drug: gemcitabine; Drug: carboplatin; Drug: cisplatin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00191230

5489

B9E-US-S236

Details and patient eligibility

About

To study the efficacy and tolerability of gemcitabine/platinum chemotherapy in non small cell lung cancer

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Histologically of cytologically confirmed non small cell lung cancer
• No prior chemotherapy or radiation
• No prior malignancy

Exclusion criteria

• Pregnant or breastfeeding
• Serious concomitant systemic disorder

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)